September 21, 2014

FDA Approves Neurotoxic Flu Drug For Infants Less Than One

pin it button FDA Approves Neurotoxic Flu Drug For Infants Less Than One

pharma influenza FDA Approves Neurotoxic Flu Drug For Infants Less Than One

by Sayer Ji
GreenMedInfo.com

Whereas the flu is self-limiting, the FDA’s capacity for bad decisions is not…

The recent decision by the FDA to approve the use of the antiviral drug Tamiflu for treating influenza in infants as young as two weeks old, belies an underlying trajectory within our regulatory agencies towards sheer insanity.

Tamiflu, known generically as oseltamivir, has already drawn international concern over its link with suicide deaths in children given the drug after its approval in 1999. In fact, in 2004, the Japanese pharmaceutical company Chugai added “abnormal behavior” as a possible side effect inside Tamiflu’s package.  The FDA also acknowledged in its April, 2012 “Pediatric Postmarket Adverse Event Review” of Tamiflu that “abnormal behavior, delirium, including symptoms such as hallucinations, agitation, anxiety, altered level of consciousness, confusion, nightmares, delusions” are possible side effects.[i]

Recent animal research on Tamiflu has found that the infant brain absorbs the drug more readily than the adult brain,[ii]  [iii]lending a possible explanation for why neuropsychiatric side effects have been observed disproportionately in younger patients.

The very mechanism of Tamiflu’s anti-influenza action may hold the key to its well-known neurotoxicity. Known as a neuromindase inhibitor, the drug inhibits the key enzyme within the flu virus that enables it to enter through the membrane of the host cell.  So fundamental is this enzyme that viruses are named after this antigenic characteristic. For instance,  the “N” in H1N1 flu virus is named for type 1 viral neuromindase.

Mammals, however, also have neurimindase enzymes, known as ‘sialidase homologs,’ with four variations identified within the human genome so far; NEU1,NEU2,NEU3 and NUE4.  These enzymes are important for neurological health. For example, the enzyme encoded by NEU3, is indispensable for the modulation of the ganglioside content of the lipid bilayer, which is found predominantly in the nervous system and constitutes 6% of all phospholipids in the brain.

It is therefore likely that neurimindase-targeted drugs like Tamiflu are simply not selective enough to inhibit only the enzymes associated with influenza viral infectivity. They likely also cross-react with those off-target neurimindase enzymes associated with proper neurological function within the host. This “cross reactivity” with self-structures may also explain why the offspring of pregnant women given Tamiflu have significantly elevated risk of birth defects (10.6%) relative to background rates (2-3%), according to a 2009 safety review by the European Medicines Agency.

Beyond the recognition of Tamiflu’s intrinsic toxicity, there are two additional problems with the use Tamiflu in infants:

  1. Infants do not yet have a sufficiently developed blood-brain barrier capable of keeping the chemical out of their rapidly developing brains
  2. Their detoxification systems are not sufficiently developed to remove the chemical rapidly enough to prevent harm

The FDA’s decision to include infants under one as treatable with Tamiflu is all the more disturbing when you consider that a 2010 study published in The Pediatric Infectious Disease Journal found that of 157 evaluable infants (mean age 6.3 months) treated for influenza with Tamiflu, complications due to the medication were found in the majority (54%) of the treated group.

According to the study

Complications were recorded in 84 patients (54%), the most serious of which were meningitis in 1 infant (1%), pneumonia in 9 (6%), and otitis media in 2 (1%).

Are meningitis, pneumonia and otitis media (ear infection) acceptable risks for treating influenza? Apparently for the FDA, it is.

How about death? Is that an acceptable risk of Tamiflu treatment for flu, a self-limiting disease?

In 2011, the International Journal of Vaccine Risk and Safety in Medicine published an article titled, “Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza,” described 119 reports of Tamiflu-induced death. According to the study:  “of 119 deaths after Tamiflu was prescribed, 38 deteriorated within 12 hours (28 within 6 hours).”

The study concluded:

These data suggest Tamiflu use could induce sudden deterioration leading to death especially within 12 hours of prescription. These findings are consistent with sudden deaths observed in a series of animal toxicity studies, several reported case series and the results of prospective cohort studies. From “the precautionary principle” the potential harm of Tamiflu should be taken into account and further detailed studies should be conducted.

So, how did the FDA justify its decision to consider Tamiflu safe in infants under one year? Did it use controlled, randomized, placebo-controlled trials to ascertain safety?  Of course not. Testing drugs on infants is unethical, and no parent in their right mind would enroll their newborn in such a trial. Lacking definitive evidence of safety, the FDA’s expanded approval in children younger than one year was based on extrapolation of data from previous results in adults and older children.[iv] This, of course, is inappropriate as it denies the aforementioned differences in the susceptibility to drug toxicity and neurotoxicity between infants and older individuals.  It also avoids proper consideration of the studies in the biomedical literature indicating its potential for severe, if not life-threatening toxicity to infants, children and adults alike.

Another concern, not addressed in the FDA announcement, is that as of Dec. 15th, 2010, the World Health Organization has acknowledged that, based on over 300 tested worldwide samples of the 2009 pandemic H1N1 flu, resistance to Tamiflu is growing.[v]  Therefore, treating an infant with Tamiflu-resistant influenza would not only do nothing to combat the infection, but would poison that child and further disable their natural immune response.

The clear winner in the FDA’s decision will be the bottom line of Roche, the manufacturer of this patented chemical.  How much longer can the FDA continue to expect those subject to its regulatory decisions to maintain the illusion that it is interested in the public welfare?

We must remember that infants do not get sick from the flu as a result of Tamiflu deficiency, or flu vaccine deficiency for that matter.  They do get sick from the immune-disrupting effects of synthetic chemicals completely foreign to human physiology (such as Tamiflu), and lack of vital hormone modulating compounds that result from adequate sunlight exposure (vitamin D3), and good nutrition.

For additional information on this topic view our research on natural anti-influenza agents.

Read the full article here: http://www.greenmedinfo.com/blog/fda-approves-neurotoxic-flu-drug-infants-less-one

Flu and Flu Vaccines:
What’s Coming Through That Needle – DVD

flu and flu vaccines whats coming through that needle DVD by dr tenpenny FDA Approves Neurotoxic Flu Drug For Infants Less Than One

More Info
FREE Shipping Available!


0 commentsback to post

Other articlesgo to homepage

Liberian Scientist and Professor: Ebola Virus Manufactured by Western Pharmaceuticals, US DoD?

Liberian Scientist and Professor: Ebola Virus Manufactured by Western Pharmaceuticals, US DoD?

Pin It

This editorial written by Dr. Cyril Broderick, a former professor of Plant Pathology at the University of Liberia’s College of Agriculture and Forestry, was published by Liberia’s largest newspaper as headline news. He claims that Ebola is a genetically modified organism (GMO) introduced by western medicine and possibly a result of military research.

The western pro-pharma media has chided Dr. Broderick, saying that such an inflammatory piece of writing is “irresponsible” since so many Africans are already distrustful of western medicine. They see western medicine as the answer to Africa’s deadly diseases such as Ebola, while Dr. Borderick sees it as the cause. Dr. Broderick states “African people are not ignorant and gullible, as is being implicated.”

Whether right or wrong, we feel African leaders have a voice in this matter, and should not be censored.

New GAO Report on Obamacare: Security Leaks, Cover Ups, and Lies

New GAO Report on Obamacare: Security Leaks, Cover Ups, and Lies

Pin It

The U.S. Government Accountability Office (GAO) released its report this week on Obamacare. The report shows massive security flaws, cover-ups, and lies. Is this the new norm for government overseeing health matters? The GAO is also expected to soon conclude a report on the Vaccine Injury Compensation Trust Fund which has accumulated $3.5 BILLION in 2014.

CDC Whistleblower Dr. Thompson: “I’ve Stopped Lying” – Willing to Testify on Vaccine Fraud

CDC Whistleblower Dr. Thompson: “I’ve Stopped Lying” – Willing to Testify on Vaccine Fraud

Pin It

The Autism Media Channel has released another video from CDC Whistleblower Dr. William Thompson, confessing to the fact that he was asked by his boss to lie, and that he’s now “stopped lying.”

In the video, Thompson states that the CDC has “become paralyzed” over the vaccine-autism issue. He states that the whole branch of the vaccine division is “becoming more paralyzed, with less and less being done.”

This failure by the CDC to investigate why vaccines cause autism in some children has “put the research 10 years behind” according to Thompson. He states that “because the CDC has not been transparent, we missed 10 years of research.”

Thompson goes on to state that we need Congress to come in and look at all the data related to vaccines and autism that has been previously withheld by the CDC, and have an independent contractor look at it. Thompson makes it clear that he is ready to testify before Congress, if asked to do so.

How the Government has Earned $3.5 BILLION from the Claim that Vaccines Don’t Cause Autism

How the Government has Earned $3.5 BILLION from the Claim that Vaccines Don’t Cause Autism

Pin It

Few among the American public truly understand just how huge the U.S. vaccine market is. Not only do drug companies reap huge profits from vaccines, so too does the U.S. government.

For example, did you know that the U.S. Department of Health and Human Services has accumulated $3.5 BILLION in vaccine tax revenue which is currently “sitting” in the Vaccine Injury Compensation Trust Fund?

This trust fund was established in 1988 “to compensate vaccine-related injury or death claims for covered vaccines.” The money in this fund comes from a $0.75 excise tax on vaccines recommended by the CDC.

So why does this Trust Fund have such a high balance, instead of paying medical expenses to families with vaccine damaged children? Probably because the government has decided that vaccines do not cause autism, the most common claim filed in the National Vaccine Injury Compensation Program since its inception in 1986.

Boy Held by Chicago Hospital in Medical Kidnapping Case Returns Home

Boy Held by Chicago Hospital in Medical Kidnapping Case Returns Home

Pin It

Local Fox News affiliate Fox4kc in Kansas City has reported that 17-year-old Isaiah Rider has returned home to Kansas City, even though the State of Illinois still retains his custody rights. Isaiah was released from Luries Children’s Hospital in Chicago where he was being held against his will, and the will of his family. He is reportedly staying with grandparents while his mother fights back against “medical abuse” charges for disagreeing with the hospital’s treatment and wanting to transfer him to a different hospital. Isaiah lost 5 months of his life to confinement in a hospital, and is now anxious to get back to school and resume his life.

Isaiah’s mother Michelle believes they held her son to conduct medical experimentation on his rare disease, Neurofibromatosis. Michelle will return to Chicago Friday to face trial. But in the meantime, at least Isaiah is back home in Kansas City, staying with his grandparents.

read more


Get the news right in your inbox!